Physician profile
Mitchell Nash
NPI 1407484967
$914.48
in general payments reported to CMS, 2019-2025
9 companies · $777 in 2025
The $777 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.79 · 2024: $115 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $227.21 | 2021-2025 | |
| Tarsus Pharmaceuticals, INC. | $211.49 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $128.84 | 2024-2025 | Acthar |
| Astellas Pharma Global Development | $92.09 | 2025 | Izervay |
| Alcon Vision LLC | $87.68 | 2024-2025 | Verion, Clareon, Clareon Panoptix Pro |
| Regeneron Pharmaceuticals, INC. | $59.05 | 2025 | Eylea Hd |
| Sun Pharmaceutical Industries INC. | $56.82 | 2024-2025 | |
| Dompe US, INC. | $28.88 | 2025 | Oxervate |
| Rxsight INC | $22.42 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.